Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 630-641

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetic analysis of the microemulsion formulation of cyclosporin A (Neoral^®®) in renal transplant patients

By Xuan Dawei   Nightingale Charles H   Hull David   Nicolau David P  

Therapy, Vol. 3, Iss. 2, 2006-03 ,pp. : 259-264

Future Medicine

Access to resources Recommend Favorite

Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. S183, 2015-05 ,pp. : 16-22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients

By                        

International Journal of Molecular Medicine, Vol. 28, Iss. 6, 2011-01 ,pp. : 1093-1102

Spandidos Publications

Access to resources Recommend Favorite

CORRIGENDUM: Identification and Characterization of a Defective CYP3A4 Genotype in a Kidney Transplant Patient With Severely Diminished Tacrolimus Clearance

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 5, 2014-11 ,pp. : 625-625

John Wiley & Sons Inc

Access to resources Recommend Favorite